Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Open in API
Filings indexed 1,320 across all filing types
Latest filing 2024-04-30 Remuneration Information
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA - Notice of the Annual General Meeting 23 May 2024
Remuneration Information Classification · 98% confidence The document is explicitly titled "REPORT ON REMUNERATION TO SENIOR EXECUTIVES FOR 2023" and details the compensation structure, fixed pay, variable pay, and share-based remuneration for the CEO and other senior management for the financial year 2023. This content directly aligns with the definition of a report detailing compensation for top executives and directors. The specific filing category for this is 'Remuneration Information' (Code: DEF 14A), which is often used for proxy statements or related disclosures concerning executive pay, even if the document itself is a standalone report prepared for the AGM.
2024-04-30 English
Photocure ASA - Notice of the Annual General Meeting 23 May 2024
AGM Information Classification · 98% confidence The document is explicitly titled "REPORT AND RECOMMENDATIONS FROM THE NOMINATION COMMITTEE IN PHOTOCURE TO THE ANNUAL GENERAL MEETING TO BE HELD ON MAY 23, 2024". It details the committee's mandate, proposed composition of the Board of Directors, and proposed remuneration for board members, all of which are standard items presented to shareholders for approval at an Annual General Meeting (AGM). While it relates to board composition and remuneration (which have related codes like MANG and DEF 14A), the context is a formal report *for* the AGM, making it highly relevant to AGM materials. Since it is a formal report/recommendation document intended for shareholder review ahead of the meeting, and not just a simple announcement of the meeting date or voting results, it aligns best with AGM-related materials. Given the options, AGM-R (AGM Information) is the most appropriate classification for a Nomination Committee report presented to the AGM.
2024-04-30 English
Photocure ASA - Notice of the Annual General Meeting 23 May 2024
AGM Information Classification · 98% confidence The document explicitly states it is a "Notice of the Annual General Meeting 23 May 2024". It details the date, time, and virtual nature of the AGM, and mentions that the agenda and proposals are enclosed with the notification. This directly corresponds to the definition of AGM Information, which covers presentations and materials shared during the Annual General Meeting. Although it is a notice, the content is central to the AGM event itself, making AGM-R the most appropriate classification over a general RPA or RNS, as it is a specific type of meeting material announcement.
2024-04-30 English
Photocure ASA - Notice of the Annual General Meeting 23 May 2024
AGM Information Classification · 98% confidence The document explicitly states it is a "Notice of the Annual General Meeting 23 May 2024". This directly corresponds to materials shared in relation to the Annual General Meeting (AGM). Although it is a notice, the content is specifically about convening the AGM, which aligns best with the AGM Information category (AGM-R), rather than a general Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). The document length is short (1781 chars), but the subject matter is highly specific to the AGM event itself.
2024-04-30 English
Photocure ASA: Annual Report 2023
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report 2023' and contains comprehensive sections including a Board of Directors report, financial statements, notes to financial statements, auditor's report, and ESG reporting. It covers the full fiscal year 2023 and provides detailed financial performance data, meeting the criteria for an Annual Report (10-K). FY 2023
2024-04-30 English
Photocure ASA: Annual Report 2023
Annual Report (ESEF) Classification · 100% confidence FY 2023
2024-04-30 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.